ENOV
Enovis Corporation NYSE Listed May 8, 2008$21.97
+5.37%
vs $20.85
Mkt Cap $1.3B
52w Low $20.55
8.7% of range
52w High $36.82
50d MA $23.91
200d MA $26.36
P/E (TTM)
-1.1x
EV/EBITDA
—
P/B
0.8x
Debt/Equity
0.9x
ROE
-79.5%
P/FCF
62.6x
RSI (14)
46.80
ATR (14)
$1.27
Beta
1.59
50d MA
$23.91
200d MA
$26.36
Avg Volume
1.2M
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
2711 Centerville Road · Wilmington, DE 19808 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | BMO | — | — | — | 24.85 | +1.2% | +9.7% | -2.7% | -6.6% | +4.9% | -1.1% | — |
| Feb 26, 2026 | AMC | 0.81 | 0.95 | +17.3% | 25.42 | +0.3% | +0.2% | +0.9% | -1.6% | +2.0% | -5.7% | — |
| Nov 6, 2025 | AMC | 0.67 | 0.75 | +11.9% | 28.42 | -1.7% | -1.3% | +7.8% | +4.1% | -0.9% | -1.2% | — |
| Aug 7, 2025 | AMC | 0.74 | 0.79 | +6.8% | 28.52 | +0.0% | -0.3% | -1.2% | +2.3% | +2.9% | -2.6% | — |
| May 8, 2025 | AMC | 0.74 | 0.81 | +9.5% | 33.08 | -1.1% | -0.1% | +10.7% | +2.1% | -3.0% | -1.4% | — |
| Feb 26, 2025 | AMC | 0.92 | 0.98 | +6.5% | 40.00 | -0.3% | -4.7% | +1.4% | -2.0% | -3.3% | +2.7% | — |
| Nov 6, 2024 | AMC | 0.63 | 0.73 | +15.9% | 46.90 | -1.2% | +2.0% | -3.0% | +2.0% | -0.9% | -1.0% | — |
| Aug 7, 2024 | AMC | 0.60 | 0.62 | +3.3% | 40.57 | +2.4% | +7.4% | -0.4% | -2.3% | +2.1% | -0.6% | — |
| May 2, 2024 | AMC | 0.50 | 0.50 | +0.0% | 52.13 | +0.5% | -1.6% | -0.7% | +2.6% | -3.0% | +0.8% | — |
| Feb 22, 2024 | AMC | 0.76 | 0.79 | +3.9% | 63.80 | -0.7% | -1.5% | -2.1% | -0.2% | -1.1% | -1.6% | — |
| Nov 7, 2023 | AMC | 0.53 | 0.56 | +5.7% | 48.33 | +0.4% | -0.2% | -1.9% | +1.1% | +0.7% | +4.2% | — |
| Aug 3, 2023 | AMC | 0.53 | 0.61 | +15.1% | 58.96 | +1.6% | +0.5% | -0.3% | -2.2% | -2.0% | -1.3% | — |
| May 4, 2023 | AMC | 0.37 | 0.44 | +18.9% | 57.54 | +1.1% | -0.2% | -0.9% | -1.0% | -0.6% | -0.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 6 | Evercore ISI | Maintains | Outperform → Outperform | — | $22.64 | $22.33 | -1.4% | +0.5% | -1.1% | +5.6% | +0.9% | +1.8% |
| Feb 26 | BTIG | Maintains | Buy → Buy | — | $22.32 | $22.62 | +1.3% | +13.9% | +0.2% | +0.9% | -1.6% | +2.0% |
| Feb 26 | Needham | Maintains | Buy → Buy | — | $22.32 | $22.62 | +1.3% | +13.9% | +0.2% | +0.9% | -1.6% | +2.0% |
| Dec 17 | Canaccord Genuity | Maintains | Buy → Buy | — | $26.07 | $26.63 | +2.1% | +4.9% | -0.1% | -2.0% | +1.6% | -3.3% |
| Nov 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $28.42 | $27.95 | -1.7% | -1.3% | +7.8% | +4.1% | -0.9% | -1.2% |
| Aug 8 | Wells Fargo | Maintains | Overweight → Overweight | — | $28.52 | $28.53 | +0.0% | -0.3% | -1.2% | +2.3% | +2.9% | -2.6% |
| Aug 8 | UBS | Maintains | Buy → Buy | — | $28.52 | $28.53 | +0.0% | -0.3% | -1.2% | +2.3% | +2.9% | -2.6% |
| Aug 8 | Canaccord Genuity | Maintains | Buy → Buy | — | $28.52 | $28.53 | +0.0% | -0.3% | -1.2% | +2.3% | +2.9% | -2.6% |
| Aug 7 | Needham | Maintains | Buy → Buy | — | $25.76 | $27.58 | +7.1% | +10.7% | -0.3% | -1.2% | +2.3% | +2.9% |
| Jul 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $33.02 | $33.30 | +0.8% | +5.2% | +2.4% | +1.1% | -5.3% | -6.1% |
| May 14 | Canaccord Genuity | Maintains | Buy → Buy | — | $37.35 | $37.05 | -0.8% | -3.0% | -1.4% | +0.9% | -1.6% | -2.8% |
| May 9 | Needham | Maintains | Buy → Buy | — | $33.08 | $32.72 | -1.1% | -0.1% | +10.7% | +2.1% | -3.0% | -1.4% |
| May 9 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $33.08 | $32.72 | -1.1% | -0.1% | +10.7% | +2.1% | -3.0% | -1.4% |
| Apr 9 | Needham | Maintains | Buy → Buy | — | $30.66 | $30.00 | -2.2% | +11.6% | -6.2% | -0.3% | +0.9% | -2.6% |
| Apr 2 | Needham | Maintains | Buy → Buy | — | $37.18 | $35.81 | -3.7% | -0.5% | -8.6% | -3.7% | -0.1% | -5.7% |
| Feb 27 | Needham | Maintains | Buy → Buy | — | $40.00 | $39.88 | -0.3% | -4.7% | +1.4% | -2.0% | -3.3% | +2.7% |
| Nov 7 | Needham | Maintains | Buy → Buy | — | $46.90 | $46.34 | -1.2% | +2.0% | -3.0% | +2.0% | -0.9% | -1.0% |
| Oct 1 | Evercore ISI | Maintains | Outperform → Outperform | — | $43.05 | $42.75 | -0.7% | -3.7% | -1.5% | -2.2% | +1.8% | -2.6% |
| Aug 8 | JP Morgan | Maintains | Neutral → Neutral | — | $40.57 | $41.54 | +2.4% | +7.4% | -0.4% | -2.3% | +2.1% | -0.6% |
| Aug 8 | Needham | Maintains | Buy → Buy | — | $40.57 | $41.54 | +2.4% | +7.4% | -0.4% | -2.3% | +2.1% | -0.6% |
| Jul 2 | Evercore ISI | Maintains | Outperform → Outperform | — | $44.35 | $44.35 | +0.0% | +0.8% | -0.6% | +0.9% | -1.0% | -1.4% |
| May 3 | Needham | Maintains | Buy → Buy | — | $52.13 | $52.37 | +0.5% | -1.6% | -0.7% | +2.6% | -3.0% | +0.8% |
| Apr 10 | Needham | Maintains | Buy → Buy | — | $62.43 | $61.79 | -1.0% | -4.0% | -0.3% | -2.1% | -3.0% | -0.5% |
| Feb 23 | Wells Fargo | Maintains | Overweight → Overweight | — | $63.80 | $63.38 | -0.7% | -1.5% | -2.1% | -0.2% | -1.1% | -1.6% |
| Feb 23 | Needham | Maintains | Buy → Buy | — | $63.80 | $63.38 | -0.7% | -1.5% | -2.1% | -0.2% | -1.1% | -1.6% |
| Feb 23 | Canaccord Genuity | Maintains | Buy → Buy | — | $63.80 | $63.38 | -0.7% | -1.5% | -2.1% | -0.2% | -1.1% | -1.6% |
| Jan 8 | Needham | Maintains | Buy → Buy | — | $56.21 | $56.88 | +1.2% | +2.0% | +1.1% | +0.8% | -0.5% | -0.4% |
| Dec 20 | Canaccord Genuity | Maintains | Buy → Buy | — | $55.45 | $55.90 | +0.8% | -0.9% | +2.9% | +0.9% | -0.4% | -0.4% |
| Dec 15 | Needham | Maintains | Buy → Buy | — | $53.70 | $54.34 | +1.2% | -0.1% | +0.8% | +2.6% | -0.9% | +2.9% |
| Nov 8 | Needham | Maintains | Buy → Buy | — | $48.33 | $48.52 | +0.4% | -0.2% | -1.9% | +1.1% | +0.7% | +4.2% |
| Oct 20 | Needham | Maintains | Buy → Buy | — | $44.86 | $44.58 | -0.6% | -0.9% | +2.4% | +0.5% | -3.4% | -1.1% |
| Aug 4 | Needham | Maintains | Buy → Buy | — | $58.96 | $59.92 | +1.6% | +0.5% | -0.3% | -2.2% | -2.0% | -1.3% |
| Aug 4 | Baird | Maintains | Outperform → Outperform | — | $58.96 | $59.92 | +1.6% | +0.5% | -0.3% | -2.2% | -2.0% | -1.3% |
| May 12 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $55.79 | $57.17 | +2.5% | +1.3% | +1.3% | -0.9% | -1.7% | -1.3% |
| May 5 | Baird | Maintains | Outperform → Outperform | — | $57.54 | $58.15 | +1.1% | -0.2% | -0.9% | -1.0% | -0.6% | -0.4% |
| Mar 28 | Canaccord Genuity | Maintains | Buy → Buy | — | $50.32 | $49.93 | -0.8% | +0.2% | +3.6% | +1.3% | +1.1% | -0.0% |
| Feb 24 | Baird | Maintains | Outperform → Outperform | — | $57.62 | $56.64 | -1.7% | -3.1% | +2.5% | +0.7% | -0.5% | -0.2% |
| Nov 3 | Baird | Maintains | Outperform → Outperform | — | $47.86 | $46.45 | -2.9% | +6.8% | +1.0% | +3.2% | -1.0% | -1.7% |
| Oct 26 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $48.57 | $48.52 | -0.1% | +2.5% | -1.6% | +2.2% | -1.2% | +0.2% |
| Oct 12 | Jefferies | Maintains | Buy → Buy | — | $44.83 | $45.22 | +0.9% | +0.6% | +2.8% | -2.9% | +5.7% | +0.2% |
| Oct 11 | Goldman Sachs | Maintains | Buy → Buy | — | $44.86 | $45.11 | +0.6% | -0.1% | +0.6% | +2.8% | -2.9% | +5.7% |
| Sep 12 | Evercore ISI | Maintains | Outperform → Outperform | — | $51.55 | $52.41 | +1.7% | +6.0% | -4.9% | +1.6% | -0.3% | -2.5% |
| Sep 12 | Canaccord Genuity | Maintains | Buy → Buy | — | $51.55 | $52.41 | +1.7% | +6.0% | -4.9% | +1.6% | -0.3% | -2.5% |
| Jun 28 | Argus | Maintains | Hold → Hold | — | $58.99 | $58.54 | -0.8% | -4.3% | -1.4% | -1.2% | +1.8% | -0.7% |
| Jun 16 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $61.20 | $59.90 | -2.1% | -6.6% | -1.2% | -1.1% | -1.0% | +0.3% |
| Apr 21 | KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | — | $70.47 | $70.35 | -0.2% | -3.0% | -1.9% | +0.5% | -1.2% | -2.4% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Engert Oliver | Chief Administrative Officer | Buy | 1,000 | $20.92 | $21K | 53,640 | -3.38% | — |
| Jun 11, 2026 | Engert Oliver | Chief Administrative Officer | Buy | 1,000 | $21.75 | $22K | 51,840 | +2.86% | — |
| Jun 11, 2026 | Engert Oliver | Chief Administrative Officer | Buy | 200 | $20.99 | $4K | 50,840 | +2.86% | — |
| Jun 10, 2026 | Engert Oliver | Chief Administrative Officer | Buy | 1,000 | $23.00 | $23K | 50,640 | +3.22% | +5.37% |
| Jun 1, 2026 | Engert Oliver | Chief Administrative Officer | Buy | 1,000 | $22.22 | $22K | 49,640 | +6.03% | -8.31% |
8-K · 5.02
!!! Very High
Enovis Corporation -- 8-K 5.02: Executive Change
May 19
8-K · 2.02
!! High
Enovis Corporation -- 8-K 2.02: Earnings Results
Enovis reported first-quarter 2026 earnings results on May 7, 2026, providing investors with updated financial performance metrics for the period ending April 3, 2026.
May 7
8-K
Enovis Corporation -- 8-K Filing
Enovis Corporation reported 4% year-over-year growth in Prevention Recovery sales for Q4 2025, demonstrating modest organic expansion in its medical technology segment.
Feb 26
8-K
Middleby Corp -- 8-K Filing
Middleby Corp appointed Christopher Hix to its board of directors, expanding its governance structure with a new board member.
Feb 4
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Portfolio Management Llc | 3,808,629 | $87M | New | Mar 2026 |
| 2 | Morgan Stanley | 2,210,476 | $59M | Added | Dec 2025 |
| 3 | Vanguard Capital Management Llc | 2,552,351 | $58M | New | Mar 2026 |
| 4 | Hood River Capital Management Llc | 1,756,669 | $40M | Added | Mar 2026 |
| 5 | River Road Asset Management, Llc | 1,502,982 | $34M | Added | Mar 2026 |
| 6 | Fmr Llc | 1,362,597 | $31M | Reduced | Mar 2026 |
| 7 | Nuveen, Llc | 1,162,970 | $26M | Added | Mar 2026 |
| 8 | Allspring Global Investments Holdings, Llc | 1,045,360 | $24M | Added | Mar 2026 |
| 9 | Private Management Group Inc | 983,377 | $22M | New | Mar 2026 |
| 10 | Ubs Group Ag | 821,906 | $19M | Added | Mar 2026 |
| 11 | Citadel Advisors Llc | 781,761 | $18M | Added | Mar 2026 |
| 12 | Front Street Capital Management, Inc. | 746,056 | $17M | New | Mar 2026 |
| 13 | Royal Bank Of Canada | 728,797 | $17M | Reduced | Mar 2026 |
| 14 | Bank Of America Corp /de/ | 685,674 | $16M | Reduced | Mar 2026 |
| 15 | Northern Trust Corp | 635,719 | $14M | Added | Mar 2026 |
| 16 | Millennium Management | 629,316 | $14M | Added | Mar 2026 |
| 17 | Tributary Capital Management, Llc | 527,707 | $14M | New | Dec 2025 |
| 18 | Quantinno Capital Management Lp | 604,500 | $14M | Added | Mar 2026 |
| 19 | Man Group Plc | 528,666 | $12M | Added | Mar 2026 |
| 20 | Park West Asset Management Llc | 520,592 | $12M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$1.26B
Enterprise Value
$2.47B
P/E (TTM)
-1.05x
Forward P/E
6.13x
PEG Ratio
-0.03x
P/B
0.84x
P/S
0.56x
P/FCF
62.65x
EV/EBITDA
—
Shares Out
56.8M
Financials (TTM)
Revenue
$2.25B
Net Income
-$1.18B
EBITDA
-$830.2M
Free Cash Flow
$19.9M
Op Cash Flow
$217.3M
EPS Basic
$-20.86
EPS Diluted
$-20.86
EPS Forward
$3.58
Gross Margin
59.8%
Op Margin
-52.6%
Net Margin
-52.7%
Balance Sheet
Total Assets
$3.83B
Total Liab.
$2.34B
Total Equity
$1.49B
Cash
$36.4M
LT Debt
$1.26B
Book Value/Sh
$26.27
Debt/Equity
0.93x
Current Ratio
2.02
Quick Ratio
1.04
Returns & Growth
ROE
-79.5%
ROA
-30.9%
ROIC
-35.9%
Rev Growth YoY
+6.7%
EPS Growth YoY
-39.7%
Price Returns
2W
-13.2%
1M
-3.2%
3M
-11.0%
6M
-25.1%
12M
-27.5%
Technicals
52W High
$36.82
52W Low
$20.55
50d MA
$23.91
200d MA
$26.36
RSI (14)
46.80
ATR (14)
$1.27
Beta
1.59
Avg Volume
1.2M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$46.60
High
$52.00
Low
$40.00
Median
$50.00
Data updated apr 25, 2026 7:11am
· Source: financialmodelingprep.com